Amgen Inc

AMGN

NASDAQ. Currency in USD

285.94 -0.46 ( -0.16% )

Real time prices: December 01

Market Cap.
152.57B
Beta (5Y monthly)
0.64
Price/Earnings
15.78
EPS (TTM)
17.96
Forward Dividend
7.76 (2.75%)
Ex-Dividend Date
Nov 17, 2022
Volume
2.91M
1y Target Est.
265.19
Day's Range
279.88
-
288.09
52 Week's Range
200.84
-
296.67

Historical Summary

Performance
EPS growth
Share Buybacks

About Amgen Inc

Sector
Healthcare
Industry
Drug Manufacturers-General
Website
https://www.amgen.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
563.27M
Employees
24200
Address
One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Latest news

The S&P 500 is on the cusp of breaking through a level that might spell the end of the bear market
The S&P 500 is on the cusp of breaking through a level that might spell the end of the bear market

Still, new 52-week highs made by individual stocks is low, putting on hold a 'buy'...
By MarketWatch - 13 hours ago

Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout
Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout

Horizon Therapeutics Plc (NASDAQ: HZNP) confirmed it's engaged in preliminary talks with Amgen Inc (NASDAQ:...
By Benzinga - 1 day ago

Horizon (HZNP) Up on Initial Talks of Buyout by Pharma Giants
Horizon (HZNP) Up on Initial Talks of Buyout by Pharma Giants

Horizon (HZNP) holds preliminary discussions with Amgen, Sanofi and Janssen, a subsidiary of J&J, seeking...
By Zacks Investment Research - 1 day ago

Why Horizon Therapeutics Stock Is Skyrocketing Today
Why Horizon Therapeutics Stock Is Skyrocketing Today

Three big drugmakers could be interested in acquiring Horizon.
By The Motley Fool - 1 day ago

Beat the Market the Zacks Way: Tenaris, Lululemon, AutoZone in Focus
Beat the Market the Zacks Way: Tenaris, Lululemon, AutoZone in Focus

Our time-tested methodologies were at work to help investors navigate the market well last week....
By Zacks Investment Research - 3 days ago

Why Millennials Should Aim For $4 Million For Retirement
Why Millennials Should Aim For $4 Million For Retirement

We discuss how young folks in their early 30s can aim and accumulate a large...
By Seeking Alpha - 5 days ago